Gut microbiota and IBD;Microbiote intestinal et MICI.

Gastroenterologie Clinique et Biologique

Volumn 34, Issue SUPPL. 1, 2010, Pages

  Seksik, P ^a,b  

^a HÔPITAL SAINT ANTOINE   (France)

^b UPMC   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CLARITHROMYCIN; CLOFAZIMINE; CORTICOSTEROID; DEFENSIN; ETHAMBUTOL; I KAPPA B; IMMUNOGLOBULIN G; ISONIAZID; MITOGEN ACTIVATED PROTEIN KINASE; MURAMYL DIPEPTIDE; RIFABUTIN;

ACTINOBACTERIA; ADHERENT INVASIVE ESCHERICHIA COLI; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL CELL; BACTERIAL STRAIN; BACTEROIDETES; BIFIDOBACTERIACEAE; BIODIVERSITY; BLOOD SAMPLING; CHRONIC INFLAMMATION; CLINICAL ASSESSMENT; COLITIS; COLON BIOPSY; COLON FLORA; CROHN DISEASE; ESCHERICHIA COLI; EXPERIMENTAL MODEL; FIRMICUTES; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; HOMEOSTASIS; IMMUNE RESPONSE; INTESTINE FLORA; LACTOBACILLUS; MICROBIAL COMMUNITY; MUCOSA ASSOCIATED MICROBIOTA; NONHUMAN; PARATUBERCULOSIS; PATHOGENESIS; PATHOGENICITY; PROTEOBACTERIA; SEROLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS; ANIMAL; ENTERITIS; EVIDENCE BASED MEDICINE; GENETICS; HUMAN; INTESTINE; ISOLATION AND PURIFICATION; METAGENOME; MICROBIOLOGY; PATHOLOGY;

ACTINOBACTERIA; ANIMALS; BACTEROIDETES; EVIDENCE-BASED MEDICINE; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINES; METAGENOME; PROTEOBACTERIA;

EID: 77957326958     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0399-8320(10)70020-8     Document Type: Article

References (48)

1. Elson C.O., Sartor R.B., Tennyson G.S., Riddell R.H. Experimental models of inflammatory bowel disease. Gastroenterology 1995, 109:1344-1367.
2. Swidsinski A., Ladhoff A., Pernthaler A., Swidsinski S., Loening-Baucke V., Ortner M., et al. Mucosal flora in inflammatory bowel disease. Gastroenterology 2002, 122:44-54.
3. Harper P.H., Lee E.C., Kettlewell M.G., Bennett M.K., Jewell D.P. Role of the faecal stream in the maintenance of Crohn's colitis. Gut 1985, 26:279-284.
4. Rutgeerts P, Goboes K, Peeters M, Hiele M, Penninckx F, Aerts R, et al. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet 199;338:771-4.
5. Llopis M., Antolin M., Guarner F., Salas A., Malagelada J.R. Mucosal colonisation with Lactobacillus casei mitigates barrier injury induced by exposure to trinitronbenzene sulphonic acid. Gut 2005, 54:955-959.
6. Kim S.C., Tonkonogy S.L., Albright C.A., Tsang J., Balish E.J., Braun J., et al. Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology 2005, 128:891-906.
7. Garrett W.S., Lord G.M., Punit S., Lugo-Villarino G., Mazmanian S.K., Ito S., et al. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell 2007, 131:33-45.
8. Hugot J.P., Chamaillard M., Zouali H., Lesage S., Cézard J.P., Belaiche J., et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001, 411:599-603.
9. Kobayashi K.S., Chamaillard M., Ogura Y., Henegariu O., Inohara N., Nuñez G., et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 2005, 307:731-734.
10. Economou M., Trikalinos T.A., Loizou K.T., Tsianos E.V., Ioannidis J.P. Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis. Am J Gastroenterol 2004, 99:2393-2404.
11. Duerr R.H., Taylor K.D., Brant S.R., Rioux J.D., Silverberg M.S., Daly M.J., et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006, 314:1461-1463.
12. Rioux J.D., Xavier R.J., Taylor K.D., Silverberg M.S., Goyette P., Huett A., et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 2007, 39:596-604.
13. Wehkamp J., Harder J., Weichenthal M., Schwab M., Schäffeler E., Schlee M., et al. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal {alpha}-defensin expression. Gut 2004, 53:1658-1664.
14. Wehkamp J., Harder J., Weichenthal M., et al. Inducible and constitutive beta-defensins are differentially expressed in Crohn's disease and ulcerative colitis. Inflamm Bowel Dis 2003, 9:215-223.
15. Simms L.A., Doecke J.D., Walsh M.D., Huang N., Fowler E.V., Radford-Smith G.L. Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease. Gut 2008, 57:903-910.
16. Macpherson A., Khoo U.Y., Forgacs I., Philpott-Howard J., Bjarnason I. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut 1996, 38:365-375.
17. Cohavy O., Bruckner D., Gordon L.K., Misra R., Wei B., Eggena M.E., et al. Colonic bacteria express an ulcerative colitis pANCA-related protein epitope. Infect Immun 2000, 68:1542-1548.
18. Darfeuille-Michaud A., Neut C., Barnich N., Lederman E., Di Martino P., Desreumaux P., et al. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology 1998, 115:1405-1413.
19. Darfeuille-Michaud A., Boudeau J., Bulois P., Neut C., Glasser A.L., Barnich N., et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 2004, 127:412-421.
20. Carvalho F.A., Barnich N., Sauvanet P., Darcha C., Gelot A., Darfeuille-Michaud A. Crohn's disease-associated Escherichia coli LF82 aggravates colitis in injured mouse colon via signaling by flagellin. Inflamm Bowel Dis 2008, 14:1051-1060.
21. Barnich N., Carvalho F.A., Glasser A.L., Darcha C., Jantscheff P., Allez M., et al. CEACAM6 acts as a receptor for adherentinvasive E. coli, supporting ileal mucosa colonization in Crohn disease. J Clin Invest 2007, 117:1566-1574.
22. Schwartz D., Shafran I., Romero C., Piromalli C., Biggerstaff J., Naser N., et al. Use of short-term culture for identification of Mycobacterium avium subsp. paratuberculosis in tissue from Crohn's disease patients. Clin Microbiol Infect 2000, 6:303-307.
23. Hulten K., El-Zimaity H.M., Karttunen T.J., Almashhrawi A., Schwartz M.R., Graham D.Y., et al. Detection of Mycobacterium avium subspecies paratuberculosis in Crohn's diseased tissues by in situ hybridization. Am J Gastroenterol 2001, 96:1529-1535.
24. Naser S.A., Ghobrial G., Romero C., Valentine J.F. Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease. Lancet 2004, 364:1039-1044.
25. Selby W., Pavli P., Crotty B., Florin T., Radford-Smith G., Gibson P., et al. Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease. Gastroenterology 2007, 132:2313-2319.
26. Suau A., Bonnet R., Sutren M., Godon J.J., Gibson G.R., Collins M.D., et al. Direct analysis of genes encoding 16S rRN A from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol 1999, 65:4799-4807.
27. Giaffer M.H., Holdsworth C.D., Duerden B.I. The assessment of faecal flora in patients with inflammatory bowel disease by a simplified bacteriological technique. J Med Microbiol 1991, 35:238-243.
28. Seksik P., Rigottier-Gois L., Gramet G., Sutren M., Pochart P., Marteau P., et al. Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut 2003, 52:237-242.
29. Scanlan P.D., Shanahan F., O'Mahony C., Marchesi J.R. Cultureindependent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn's disease. J Clin Microbiol 2006, 44:3980-3988.
30. Sokol H., Seksik P., Rigottier-Gois L., Lay C., Lepage P., Podglajen I., et al. Specificities of the Fecal Microbiota in Inflammatory Bowel Disease. Inflamm Bowel Dis 2006, 12:106-111.
31. Mangin I., Bonnet R., Seksik P., Rigottier-Gois L., Sutren M., Bouhnik Y., et al. Molecular inventory of faecal microflora in patients with Crohn's disease. FEMS Microbiol Ecol 2004, 50:25-36.
32. Manichanh C., Rigottier-Gois L., Bonnaud E., Gloux K., Pelletier E., Frangeul L., et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 2006, 55:205-211.
33. Sokol H., Lepage P., Seksik P., Dore J., Marteau P. Temperature Gradient Gel Electrophoresis of Fecal 16S rRNA Reveals Active Escherichia coli in the Microbiota of Patients with Ulcerative Colitis. J Clin Microbiol 2006, 44:3172-3177.
34. Swidsinski A., Weber J., Loening-Baucke V., Hale L.P., Lochs H. Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol 2005, 43:3380-3389.
35. Gophna U., Sommerfeld K., Gophna S., Doolittle W.F., Veldhuyzen van Zanten S.J. Differences between tissue-associated intestinal microfloras of patients with Crohn's disease and ulcerative colitis. J Clin Microbiol 2006, 44:4136-4141.
36. Frank D.N., St Amand A.L., Feldman R.A., Boedeker E.C., Harpaz N., Pace N.R. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 2007, 104:13780-13785.
37. Martinez-Medina M., Aldeguer X., Gonzalez-Huix F., Acero D., Garcia-Gil L.J. Abnormal microbiota composition in the ileocolonic mucosa of Crohn's disease patients as revealed by polymerase chain reaction-denaturing gradient gel electrophoresis. Inflamm Bowel Dis 2006, 12:1136-1145.
38. Kotlowski R., Bernstein C.N., Sepehri S., Krause D.O. High prevalence of Escherichia coli belonging to the B2+ D phylogenetic group in inflammatory bowel disease. Gut 2007, 56:669-675.
39. Sokol H., Lepage P., Seksik P., Dore J., Marteau P. Molecular comparison of dominant microbiota associated with injured versus healthy mucosa in ulcerative colitis. Gut 2007, 56:152-154.
40. Zhang M., Liu B., Zhang Y., Wei H., Lei Y., Zhao L. Structural shifts of mucosa-associated lactobacilli and Clostridium leptum subgroup in patients with ulcerative colitis. J Clin Microbiol 2007, 45:496-500.
41. Mylonaki M., Rayment N.B., Rampton D.S., Hudspith B.N., Brostoff J. Molecular characterization of rectal mucosa-associated bacterial flora in inflammatory bowel disease. Inflamm Bowel Dis 2005, 11:481-487.
42. Sokol H., Pigneur B., Watterlot L., Lakhdari O., Bermúdez-Humarán L.G., Gratadoux J.J., et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 2008, 105:16731-16736.
43. Seksik P., Lepage P., de la Cochetière M.F., Bourreille A., Sutren M., Galmiche J.P., et al. Search for localized dysbiosis in Crohn's disease ulcerations by temporal temperature gradient gel electrophoresis of 16S rRNA. J Clin Microbiol 2005, 43:4654-4658.
44. Ott S.J., Musfeldt M., Wenderoth D.F., Hampe J., Brant O., Fölsch U.R., et al. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 2004, 53:685-693.
45. Giaffer M.H., Holdsworth C.D., Duerden B.I. Virulence properties of Escherichia coli strains isolated from patients with inflammatory bowel disease. Gut 1992, 33:646-650.
46. Bullock N.R., Booth J.C., Gibson G.R. Comparative composition of bacteria in the human intestinal microflora during remission and active ulcerative colitis. Curr Issues Intest Microbiol 2004, 5:59-64.
47. Pitcher M.C., Beatty E.R., Cummings J.H. The contribution of sulphate reducing bacteria and 5-aminosalicylic acid to faecal sulphide in patients with ulcerative colitis. Gut 2000, 46:64-72.
48. Conte M.P., Schippa S., Zamboni I., Penta M., Chiarini F., Seganti L., et al. Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease. Gut 2006, 55:1760-1767.